NCT01042379 · Interventional trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Overall registry status Recruiting
Phase 2
Conditions Angiosarcoma, Breast Cancer, Breast Neoplasms, Breast Tumors, Early-stage Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor Negative Tumor, Hormone Receptor Positive Tumor, Locally Advanced Breast Cancer, TNBC - Triple-Negative Breast Cancer
Delaware Valley sites
- University of Pennsylvania (U Penn) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory